Literature DB >> 22965660

Evaluation of the performance characteristics of bilayer tablets: Part II. Impact of environmental conditions on the strength of bilayer tablets.

Niranjan Kottala1, Admassu Abebe, Omar Sprockel, James Bergum, Faranak Nikfar, Alberto M Cuitiño.   

Abstract

Ambient air humidity and temperature are known to influence the mechanical strength of tablets. The objective of this work is to understand the influence of processing parameters and environmental conditions (humidity and temperature) on the strength of bilayer tablets. As part of this study, bilayer tablets were compressed with different layer ratios, dwell times, layer sequences, material properties (plastic and brittle), first and second layer forces, and lubricant concentrations. Compressed tablets were stored in stability chambers controlled at predetermined conditions (40C/45%RH, 40C/75%RH) for 1, 3, and 5 days. The axial strength of the stored tablets was measured and a statistical model was developed to determine the effects of the aforementioned factors on the strength of bilayer tablets. As part of this endeavor, a full 3 × 2(4) factorial design was executed. Responses of the experiments were analyzed using PROC GLM of SAS (SAS Institute Inc, Cary, North Carolina, USA). A model was fit using all the responses to determine the significant interactions (p < 0.05). Results of this study indicated that storage conditions and storage time have significant impact on the strength of bilayer tablets. For Avicel-lactose and lactose-Avicel tablets, tablet strength decreased with the increasing humidity and storage time. But for lactose-lactose tablets, due to the formation of solid bridges upon storage, an increase in tablet strength was observed. Significant interactions were observed between processing parameters and storage conditions on the strength of bilayer tablets.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965660      PMCID: PMC3513436          DOI: 10.1208/s12249-012-9846-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  7 in total

Review 1.  A flexible technology for modified release of drugs: multi layered tablets.

Authors:  Shajahan Abdul; S S Poddar
Journal:  J Control Release       Date:  2004-07-07       Impact factor: 9.776

2.  Fixed-dose combinations improve medication compliance: a meta-analysis.

Authors:  Sripal Bangalore; Gayathri Kamalakkannan; Sanobar Parkar; Franz H Messerli
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

3.  Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction.

Authors:  Ching Kim Tye; Changquan Calvin Sun; Gregory E Amidon
Journal:  J Pharm Sci       Date:  2005-03       Impact factor: 3.534

4.  Evaluation of the performance characteristics of bilayer tablets: Part I. Impact of material properties and process parameters on the strength of bilayer tablets.

Authors:  Niranjan Kottala; Admassu Abebe; Omar Sprockel; James Bergum; Faranak Nikfar; Alberto M Cuitiño
Journal:  AAPS PharmSciTech       Date:  2012-09-14       Impact factor: 3.246

5.  Stability of packaged solid dosage forms. II. Shelf-life prediction for packaged sugar-coated tablets liable to moisture and heat damage.

Authors:  K Nakabayashi; T Shimamoto; H Mima
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980       Impact factor: 1.645

6.  Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy.

Authors:  Calum R Park; Dale L Munday
Journal:  Int J Pharm       Date:  2002-04-26       Impact factor: 5.875

7.  A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.

Authors:  Craig LaForce; Deborah A Gentile; David P Skoner
Journal:  Postgrad Med       Date:  2008-07       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.